Cure8 trial brief
Researchers are testing a new swallowable thermal capsule that could eventually help detect temperature changes from GI inflammation. For people with Crohn’s disease or IBD, a safe, noninvasive way to sense inflammatory activity would be potentially useful if later validated in patients.
Researchers and clinicians interested in IBD diagnostics; patients and caregivers following novel noninvasive monitoring tools; adults curious about participating in early device trials.
This ClinicalTrials.gov record describes a pilot interventional study testing a wireless thermal capsule (WTC) designed to collect continuous temperature data from the human gastrointestinal tract.
The study enrolls healthy adult volunteers (planned N=25) at Massachusetts General Hospital to evaluate whether the capsule transmits valid GI temperature measurements over up to 50 hours and after stool passage.
Participants swallow the capsule while wearing an external receiver belt; staff follow participants until capsule passage and may give pro-motility agents (metoclopramide) or laxative (polyethylene glycol) if needed.
The record lists Crohn's disease and IBD as related conditions of interest for future application, but participants in this feasibility study are required to be healthy and without IBD. The study is labeled interventional and currently recruiting, described as a pilot to measure mean variance in GI temperature; planned enrollment is 25 adults aged 18–75.
Key exclusions include known GI strictures, prior intestinal surgery, diagnosed IBD, pregnancy, implanted electromedical devices, and contraindications to study medications or MRI within 7 days of capsule ingestion. If you or a patient are curious about thermal capsule technology, this trial is an early feasibility study in healthy volunteers.
It does not test efficacy in Crohn's disease patients and should not be taken as evidence of clinical benefit for IBD at this stage.
This is an early feasibility (pilot) interventional study in healthy volunteers, not a therapeutic trial in IBD patients. Results — if any — would be preliminary and intended to show the device can collect temperature data reliably; further studies would be needed to test diagnostic value in Crohn’s disease or other GI conditions.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Faster, reliable reading of capsule endoscopy videos could shorten diagnostic delays and make small-bowel evaluation easier for people with suspected Crohn’s disease. If AI preserves accuracy while reducing review time,...
Earlier detection of small-bowel Crohn’s disease with capsule endoscopy could help guide earlier or more targeted treatment and may lower flare rates, which matters to people trying to avoid disease progression and...
Measuring mucosal healing across the whole gut with stool markers, ultrasound, and capsule endoscopy may give a clearer picture of whether biologic treatment is working and help guide decisions about continuing or...
